AFM13-TARGETED BLOOD AND CORD-BLOOD-DERIVED MEMORY-LIKE NK CELLS AS THERAPY FOR CD30+MALIGNANCIES

Kerbauy, L; Marin, N; Kaplan, M; Banerjee, P; Berrien-Elliott, M; Becker-Hapak, M; Basar, R; Foster, M; Melo, LG; Neal, C; McClain, E; Daher, M; Cortes, AKN; Desai, S; Lim, FWI; Mendt, MC; Schappe, T; Li, L; Shaim, H; Sanabria, MH; Wong, P; Liu, EL; Ang, S; Cai, R; Nandivada, V; Mohanty, V; Shen, YF; Baran, N; Fowlkes, N; Chen, K; Muniz-Feliciano, L; Koch, J; Treder, M; Fischer, W; Okamoto, OK; Nieto, Y; Champlin, R; Shpall, E; Fehniger, T; Rezvani, K

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020; 8 (): A324